Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-051435

Chief Scientific Officer sold 2,146 shares at $61.99 ($133,031)

  • Chief Scientific Officer acquired 2,146 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Biller Scott Chief Scientific Officer 2017-09-01 Option exercise +2,146 $9.05 $19,421 8,410 D: show line 1 in the form
Biller Scott Chief Scientific Officer 2017-09-01 Sale −2,146 $61.99 $133,031 6,264 D: show line 2 in the form
Open-market sales · 2,146 sh · avg $61.99 · $133,031

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Biller Scott Chief Scientific Officer 2017-09-01 Option exercise · Stock option (right to buy) −2,146 35,281 D: show line 3 in the form
Loading xslF345X03/doc4.xml…